Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I. Silverberg, Raj Chovatiya, Amy S. Paller et al.|Dermatology and Therapy|2025Cited by 24